First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.

First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.
复制标题

DOI:
10.1161/hypertensionaha.110.158238
复制
发表时间:
2010-10
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
通讯作者:
Thadhani R
Thadhani R
中科院分区:
其他
文献类型:
--
作者:
Powe CE;Seely EW;Rana S;Bhan I;Ecker J;Karumanchi SA;Thadhani R

文献摘要

被引文献

相似文献

先前的研究报道了维生素D缺乏和高血压之间的联系,包括妊娠特异性疾病,先兆子痫。循环中的维生素D几乎完全与维生素D结合蛋白结合,维生素D结合蛋白在怀孕期间增加2倍,但以前的研究没有检查维生素D结合蛋白或游离维生素D水平。我们在马萨诸塞州综合医院产科产妇研究(MOMS)中进行了一项巢式病例对照研究,测量妊娠早期总25-羟基维生素D和维生素D结合蛋白,并计算游离25-羟基维生素D水平。我们比较了妊娠合并子痫前期(病例,n=39)与正常妊娠(对照,n=131)的这些水平。病例组和对照组的妊娠早期总25-羟基维生素D水平相似(27.4 ±1.9 ng/ml vs. 28.8±0.80 ng/ml,p=0.435)。尽管妊娠早期高血压与随后的先兆子痫之间存在相关性,但妊娠早期总25-羟基维生素D与妊娠早期收缩压(r=0.11,p=0.16)或舒张压(r=0.03,p=0.72)无关。尽管25-羟基维生素D水平低于15 ng/ml时有先兆子痫风险增加的趋势(OR 2.5,95% CI 0.89-6.9),但在校正体重指数和其他协变量后,这种风险降低(OR 1.35,95% CI 0.40-4.5)。妊娠早期维生素D结合蛋白和游离25-羟基维生素D水平在病例组和对照组中相似,并且与妊娠早期血压无关。这些数据表明,孕早期总的和游离的25-羟基维生素D水平与孕早期血压或随后的先兆子痫无关。
Prior studies report an association between vitamin D deficiency and hypertension, including the pregnancy-specific disorder, preeclampsia. Circulating vitamin D is almost entirely bound to vitamin D binding protein, which increases 2-fold during pregnancy, but previous studies have not examined vitamin D binding protein or free vitamin D levels. We performed a nested case-control study within the Massachusetts General Hospital Obstetrical Maternal Study (MOMS), measuring first trimester total 25-hydroxyvitamin D and vitamin D binding protein, and calculating free 25-hydroxyvitamin D levels. We compared these levels from pregnancies complicated by subsequent preeclampsia (cases, n=39) with those from normotensive pregnancies (controls, n=131). First trimester total 25-hydroxyvitamin D levels were similar in cases and controls (27.4 ±1.9 ng/ml vs. 28.8±0.80 ng/ml, p=0.435). Despite an association between higher first trimester blood pressures and subsequent preeclampsia, first trimester total 25-hydroxyvitamin D was not associated with first trimester systolic (r=0.11, p=0.16) or diastolic blood pressures (r=0.03, p=0.72). Although there was a trend toward increased risk of preeclampsia with 25-hydroxyvitamin D levels less than 15 ng/ml (OR 2.5, 95% CI 0.89-6.9), this was attenuated after adjustment for body mass index and other covariates (OR 1.35 95% CI 0.40-4.5). First trimester vitamin D binding protein and free 25-hydroxyvitamin D levels were similar in cases and controls and were not associated with first trimester blood pressures. These data suggest that first trimester total and free 25-hydroxyvitamin D levels are not independently associated with first trimester blood pressure or subsequent preeclampsia.